← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
2 та иш
Иш: Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”